ROBIN YADAV: Open Payments
NPI 1801403241 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$606 in 19 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $606
Food & beverage: $606
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $246 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $116 |
| Dendreon Pharmaceuticals LLC | 3 | $96 |
| Sumitomo Pharma America, Inc. | 2 | $46 |
| IMMUNITYBIO, INC. | 1 | $35 |
| Medtronic, Inc. | 1 | $28 |
| Antares Pharma, Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $19 |
Products named: ERLEADA, Nubeqa, PROVENGE, GEMTESA, ANKTIVA, EMPRINT, XYOSTED, Xtandi.
Industry payments across TX — which companies pay providers there.
